JP2001292728A - Obesity-preventive food - Google Patents

Obesity-preventive food

Info

Publication number
JP2001292728A
JP2001292728A JP2000112475A JP2000112475A JP2001292728A JP 2001292728 A JP2001292728 A JP 2001292728A JP 2000112475 A JP2000112475 A JP 2000112475A JP 2000112475 A JP2000112475 A JP 2000112475A JP 2001292728 A JP2001292728 A JP 2001292728A
Authority
JP
Japan
Prior art keywords
food
lipolytic enzyme
enzyme
lactic acid
lipolytic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000112475A
Other languages
Japanese (ja)
Inventor
Fujiharu Yanagida
藤治 柳田
Kunio Sano
邦夫 佐野
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Enajikku Kk
Original Assignee
Enajikku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enajikku Kk filed Critical Enajikku Kk
Priority to JP2000112475A priority Critical patent/JP2001292728A/en
Publication of JP2001292728A publication Critical patent/JP2001292728A/en
Pending legal-status Critical Current

Links

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide an obesity-preventive food having solved such problems that microorganisms dried by an ordinary drying method mostly die out during drying, or otherwise die out or weaken during distribution or preservation as well, and also die out in the strongly acidic digestive tracts such as the stomach, therefore even if such dried live microorganisms are orally administered, they cannot directly reach the intestine and cannot have sufficient effect. SOLUTION: This obesity-preventive food is such as to be formulated with a lipolytic enzyme formed by cocultivation of yeast and lactic acid bacteria served to food, enterobacteria, proliferable oligosaccharides and vegetable fiber.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【発明の属する技術分野】本発明は、肥満防止食品に関
する。
TECHNICAL FIELD The present invention relates to a food product for preventing obesity.

【従来の技術】脂肪分解酵素は、最近では生体の調節機
能、免疫賦活作用、高血圧低下作用、腸内脂肪排除、腸
内糖質分解等を高める作用があることが明らかになって
きている。このことが消費者の間にも深く浸透し、近年
健康食品等により日本でも摂取されはじめている。脂肪
分解酵素である、例えば、ケフィール菌等は、発酵乳の
中でも長寿の国として著名であるロシア南部からトル
コ、イランに挟まれたコーカサス地方の原産で、健康増
進機能の強い発酵乳の一つとされている。ちなみに、脂
肪分解酵素であるケフィールは、スターターとして脂肪
分解酵素グレインと呼ばれるカリフラワー状の粒子(以
下脂肪分解素粒という)を牛、山羊、羊などの乳を主体
とする培地に接種して、乳酸発酵およびアルコール発酵
させたものであるが、乳酸菌のみで製造するヨーグルト
とは、異なる風味を有することを特徴としている。脂肪
分解酵素を構成している主な微生物は数十種類の乳酸菌
と酵母からなる複合共生群であることが明らかになって
いるが、その構成菌種は極めて複雑であり、その共生メ
カニズム、増殖因子、生育環境もその解明については単
純ではない。乳酸菌は、乳酸桿菌と乳酸球菌が主なもの
であるが、以下のような微生物が検出されている。スト
レプトコッカサス・ラクティス等の中温性乳酸菌群、ロ
イコノストック・メッセンテロイドス、脂肪分解酵素粒
を生成する芳香形成乳酸菌球菌群、アセトバクターアセ
チ等の酢酸菌群、カンジダ、脂肪分解酵素を生成する乳
糖発酵性酵母群、サッカロミセス・カールスベルゲンシ
ス等の乳糖非発酵性酵母群、ラクトバチル・ブレビス等
の高温性乳酸桿菌群等が検出されている。脂肪分解酵素
の作用は、乳の凝固のほかに、発酵乳の風味を良好に
し、特に過多の脂肪を効率良く分解することが知られて
いる。酵母は、乳糖発酵性酵母と乳糖非発酵性酵母から
なるが、乳糖発酵性酵母は、乳糖(糖質)を分解しアル
コールと炭酸ガスを生産する。脂肪分解酵素粒乳酸菌
は、大部分がラクトバチルス属の乳酸桿菌であるとされ
ているが、最近、脂肪分解酵素粒より新規な乳酸桿菌が
分離され、それをラクトバチルス・ケフィラノファシエ
ンスと命名されている。このことから、脂肪分解酵素粒
を構成する乳酸菌として不可欠なものは、この、ラクト
ブチルス・ケフィラノファシエンスであることも明らか
になった。
2. Description of the Related Art Recently, it has become clear that lipolytic enzymes have a function of regulating living bodies, immunostimulating effects, reducing hypertension, eliminating intestinal fat, and decomposing intestinal carbohydrates. This has penetrated deeply among consumers and has recently begun to be consumed in Japan by health foods and the like. Is a lipolytic enzyme, for example, kefir bacteria and the like, fermented milk is prominent as a country of longevity from southern Russia, Turkey, native to the Caucasus region sandwiched between Iran, one of the strong fermented milk of health promotion function Have been. By the way, kefir, a lipolytic enzyme, is used as a starter by inoculating cauliflower-like particles called lipolytic enzyme grains (hereinafter referred to as lipolytic granules) into a medium mainly composed of milk, such as cows, goats and sheep, to produce lactic acid. It is fermented and alcohol-fermented, but is characterized by having a different flavor from yogurt produced only with lactic acid bacteria. It has been revealed that the major microorganisms that constitute lipolytic enzymes are complex symbiotic groups consisting of dozens of lactic acid bacteria and yeast, but the bacterial strains are extremely complex, and their symbiotic mechanisms and growth Factors and growth environment are not simple to elucidate. Lactic acid bacteria are mainly lactobacilli and lactococci, but the following microorganisms have been detected. Mesophilic lactic acid bacteria such as Streptococcus lactis, leuconostoc mesenteroids, aroma-forming lactococci that produce lipolytic enzyme granules, acetic acid bacteria such as Acetobacter acetyl, Candida, and lactose that produces lipolytic enzyme Fermentable yeasts, lactose non-fermentable yeasts such as Saccharomyces carlsbergensis, and high-temperature lactobacilli such as lactobacillus brevis have been detected. It is known that the action of the lipolytic enzyme improves the flavor of fermented milk in addition to the coagulation of milk, and in particular, efficiently decomposes excess fat. Yeast consists of lactose-fermenting yeast and lactose-non-fermenting yeast. Lactose-fermenting yeast degrades lactose (sugar) to produce alcohol and carbon dioxide gas. Most of the lipolytic enzyme lactic acid bacteria are said to be lactobacilli of the genus Lactobacillus, but recently a new lactobacillus has been isolated from the lipolytic enzyme granules and is named Lactobacillus kefiranofaciens. Have been. From this, it became clear that Lactobacillus kefiranofaciens was indispensable as the lactic acid bacteria constituting the lipolytic enzyme granules.

【発明が解決しようとする課題】しかしながら脂肪分解
酵素を構成する菌種が完全に解明されたわけではなく、
これらの菌体がどうしてこのような共生関係を築いてい
るのか、これらの複合菌体の育成条件としてどのような
栄養分、環境が適しているかを解明するのは極めて困難
である。脂肪分解酵素は、殺菌した乳に脂肪分解酵素粒
(グレイン)を添加し約24時間発酵させたもの、はじ
めにアルコール発酵が次いで乳酸発酵が同時並行的に進
すみ炭酸ガスがかなり生成する。その後冷却して乳酸菌
や酵母の活性を抑制して保存あるいは硫通するが、炭酸
ガスの生成を完全に抑制することは不可能である。脂肪
分解酵素を、通常の乳酸菌のみで発酵した発酵乳に用い
られるような紙容器やプラスチック製の容器に充填し密
封すると、後発酵や保存中あるいは流通過程で生成した
炭酸ガスにより、容器の膨張や破裂が起こることが有
る。工業的に量産したとしても、加熱殺菌を行わずに生
菌タイプで流通させようとすると、容器に充填した後も
酵母によるアルコール二次発酵が進み、風味の劣化や炭
酸ガスによる容器膨張を起こす惧れが有る。特に、二次
発酵により容器が膨張する惧れがあり、商品として流通
過程に乗せることができない。最近では脂肪分解酵素を
生きたまま乾燥し、食することが可能な菌体乾燥食品の
実用化が望まれている。しかしながらこれらの通常の乾
燥法で乾燥した乾燥菌体は乾燥中に多くが死滅し、また
流通保存中にも死滅、または衰弱し、胃などの強酸性の
消化器官でも死滅するためこれらの乾燥生菌を経口投与
しても腸内まで生きたまま到達できず十分な効果を発揮
することができない。特に、脂肪分解酵素を必要とする
ような腸に何らかの問題のある人には腸内フローラの構
成が大腸菌など所謂悪玉菌の比率が高いと言われてお
り、そのような人の腸内では腸内pHがアルカリに傾き
脂肪分解酵素を生成する乳酸菌や酵母が増殖しにくい環
境にあるという問題がある。
However, the bacterial species constituting the lipolytic enzyme have not been completely elucidated.
It is extremely difficult to elucidate why these cells form such a symbiotic relationship and what kind of nutrients and environment are suitable as conditions for growing these composite cells. The lipolytic enzyme is obtained by adding lipolytic enzyme grains (grain) to sterilized milk and fermenting for about 24 hours. First, alcoholic fermentation and then lactic acid fermentation proceed in parallel, and considerable carbon dioxide gas is generated. After cooling, the activity of lactic acid bacteria and yeast is suppressed to preserve or sulfurate, but it is impossible to completely suppress the generation of carbon dioxide gas. When the lipolytic enzyme is filled and sealed in a paper container or plastic container used for fermented milk fermented with only lactic acid bacteria, the container expands due to carbon dioxide generated during post-fermentation, storage or distribution process. Or rupture may occur. Even if it is mass-produced industrially, if you try to distribute it as a viable cell type without heat sterilization, alcohol secondary fermentation by yeast proceeds even after filling the container, causing deterioration of flavor and expansion of the container due to carbon dioxide gas There is fear. In particular, there is a fear that the container may expand due to the secondary fermentation, and the container cannot be put on the distribution process as a commercial product. Recently, there is a demand for the practical use of bacterial cell dried foods that can dry and eat lipolytic enzymes alive. However, many of the dried cells dried by these conventional drying methods die during drying, and die or weaken during distribution storage, and die even in strongly acidic digestive organs such as the stomach. Even if the bacterium is administered orally, it cannot reach the intestine alive and cannot exert a sufficient effect. In particular, it is said that the composition of the intestinal flora has a high ratio of so-called bad bacteria such as Escherichia coli to those who have some problems in the intestine that require lipolytic enzymes. There is a problem that the lactic acid bacteria and yeast which produce lipolytic enzymes in which the internal pH is inclined toward alkali are difficult to grow.

【課題を解決するための手段】本発明者らは、上記の課
題を解決するために脂肪分解酵素の凍結乾燥による生菌
残存率を高める方法を確立し、さらに脂肪分解酵素粒の
生菌が腸内で活発に増殖するための添加物を探索した。
その結果脂肪分解酵素乾燥物に以下の物質を混合し、人
に食させたところ脂肪分解酵素がいかなる条件の人の腸
管内でも活発に増殖を開始し、腸の健康状態が改善する
ことを見出した。これは、腸内環境を改善、特に過多の
脂肪や糖質を効率良く消化吸収ならびに分解し、新陳代
謝を高め免疫賦活力も高める健康維持食品となることを
見出した。すなわち、食品に供される乳酸菌と酵母を共
生培養することにより生成された脂肪分解酵素(リパー
ゼ)と腸内細菌を関係づける事により天然植物、果実を
酸素処理してから生産させこのペクチンを含有する植
物、果実酵素処理粉末を混合することにより腸内で脂肪
分解酵素の活性が高まり理想的な脂肪分解酵素食品を製
造できることを見出した。また、特に、食品に供される
乳酸菌と酵母を共生培養することにより生成された脂肪
分解酵素(リパーゼ)と腸内細菌を関係づけた植物、果
実酵素処理粉末とオリゴ糖、カゼインホスホペプチド
(CPP)が添加されたダイエット向上食では腸内脂肪
の分解効果および腸内糖質の分解効果がさらに高まる。
また、食品に供される乳酸菌と酵母を共生培養すること
により生成された脂肪分解酵素(リパーゼ)と腸内細菌
を関係づけたことで、腸内での脂肪分解酵素の活性化と
糖質分解の活性化が高まり、かつ酵素処理にセルラー
ゼ、へミセルラーゼ、ペクチナーゼ、キシラナーゼ、ガ
ラクトピラノシダーゼ、アラビノフラノシダーゼから選
択される一種又は二種以上の酵素を使用すると腸内での
脂肪分解酵素の活性がより高まることを検証することが
できた。これらの結果から本発明が完成された。すなわ
ち、前記の課題は、食品に供される乳酸菌と酵母とを共
生培養することにより生成された脂肪分解酵素と、腸内
細菌と、増殖するオリゴ糖と、植物繊維とが配合されて
なる肥満防止食品によって解決される。本発明で使用さ
れる脂肪分解酵素は、植物繊維分解酵素であればよい
が、例えばセルラーゼ、ペクチナーゼ、キシラナーゼ、
マンナナーゼ、ガラクトピラノシダーゼ、アラビノフラ
ノシダーゼから選択される一種又は二種以上の酵素であ
ればよい。好ましくはペクチナーゼ、キシラナーゼを使
用すると腸内での脂肪分解酵素の活性がより高まる。本
発明に使用される酵素が天然抽出酵素の場合、その副成
分としてアミラーゼ、プロテアーゼ等の消化酵素を含む
ものでも使用することができる。本発明の酵素処理に使
用される酵素の添加量はその力価や処理する植物の量に
よっても異なる市販の特級試薬レベルの純度のものであ
れば植物1kgに対して1mgから100gの範囲で添
加し、酵素反応温度は5℃から50℃の範囲で10分か
ら36時間の範囲で反応させる。ペプトン、グルコー
ス、KHPO、NaNO、MgSO、PH6.
0本発明で使用される脂肪分解酵素は、市販のセルラー
ゼ等を使用することもできるが、本発明で酵素処理され
る植物としては、脂肪分解酵素の活性を促進させる植物
繊維を含むものであればよく、その例としてはミカン、
オレンジ等のミカン科、ブドウ科、キュウリ、メロン等
のウリ科、トマト、ナス等のナス科、柿等のカキ科、イ
チゴ、リンゴ、ナシ等のバラ科、ナツメ等のクロウメモ
ドキ科、ダイコン、キャベツ等のアブラナ科、ダイコ
ン、ニンジン、ゴボウ等の根菜類、サツマイモ、ヤマイ
モ等の芋類、米、麦等の穀類から選択される植物があ
る。本発明の脂肪分解酵素の活性を促進させる植物繊維
を含む植物は、脂肪分解酵素の増殖活性を調べる以下の
方法により選択した。その方法を以下に示す。調査対象
の植物10kgに精製水1000ccを入れホモジナイ
ザーでよく擦り潰し、この植物ジュースにヘミセラーゼ
を0.5g添加し、40℃で3時間インキュベートす
る。これを100℃で30分間加熱処理し、冷却後、こ
の植物セルラーゼ処理溶液と牛乳を1:9の割合で混合
し、脂肪分解酵素培養液とする。平均粒径1mmの脂肪
分解酵素グレイン20粒を上記で作成した脂肪分解酵素
培養液と共にシャーレに撒き、20℃で5日間培養す
る。この時1日ごとに培養液を交換する。培養後脂肪分
解酵素粒の形状をルーペ観察し、その増殖した平均粒径
を測定する。コントロールとして精製水で90%に稀釈
した同じ牛乳で同様に培養した脂肪分解酵素粒径を測定
し、5日後にコントロールとの粒径の大きさの比率を算
出する。この時コントロールとの粒径の比率が120%
以上有る場合、この植物を脂肪分解酵素の活性を促進さ
せるものとする。本発明に使用される植物は、できるだ
け熟成軟化したものがより適している。まず、上記で選
択された脂肪分解酵素粒の成長を促進させる植物繊維を
含む植物をミキサーで細かく粉砕し、ジュース状にす
る。この際、必要に応じて0.1から2倍重量の精製水
を加えてもよい。この植物ジュースに植物重量に対し
0.1%から5%重量のセルラーゼを添加し、10℃か
ら50℃の範閏で3時間から4時間反応させる。次に、
60℃から130℃の温度で3秒から60分間加熱処理
する。この後水分が5%以下になるまで乾燥する。乾燥
条件は、加熱乾燥でも凍結乾燥でも減圧乾燥でもよく、
特に限定されない。本発明において、上記のセルラーゼ
処理、加熱処理された植物、果実酵素処理粉末は、ダイ
エット向上食品粉末に0.5から50%重量の範囲で添
加混合される。本発明に用いられる植物、果実酵素処理
粉末は、ペクチン等の植物繊維成分およびその分解物で
もよく、ペクチンの場合は精製物、粗製物のどちらでも
利用できるが、好ましくは上記の植物のセルラーゼ処理
により植物繊維から生産されたペクチンであることが望
ましい。その理由は、精製市販ペクチンよりも本発明で
選択された植物をセルラーゼで加水分解したセルロース
の方が脂肪分解酵素の活性が高まる。しかしながら必要
に応じて市販の精製ペクチンを添加増量することもでき
る。本発明に使用される脂肪分解酵素とは、公知となっ
ている数十種類の乳酸菌と酵母からなる複合共生群(脂
肪分解酵素グレイン又は脂肪分解酵素粒と呼ばれる)か
らなるカリフラワー状の弾力を有する粒をスターターと
して発酵させて作られる発酵生産物から得られるもので
あり、乳酸菌と酵母を添加又は混合した通常の発酵食品
及びその乾燥物とは質的に異なるものである。また、本
発明に使用される脂肪分解酵素の特徴として、以下の主
要な菌種を含有し、乳酸発酵とアルコール発酵を経るも
のであり、これらの条件に当てはまる脂肪分解酵素グレ
インを使用したものであればよい。本発明に使用される
脂肪分解酵素とは、最低以下の菌種を含有するものであ
ればよい。即ち、乳酸菌としてラクトバチルス類、スト
リプトコッカス属、ラクトコカッカス類、ロイコノスト
ク類及び酵母菌としてサッカロミセス属、カンジダ等か
らなる。本発明に添加されるオリゴ糖とはフラクトオリ
ゴ糖、イソマルトオリゴ糖、ガラクトオリゴ糖(ラフィ
ノース、スタキオースを含む)、バラチノース、カップ
リングシュガー、ペクチンオリゴ等のオリゴ糖類であれ
ばよく天然抽出物、発酵製品及び化学合成品の何れも使
用できる。本発明に添加されるカゼインホスホペプチド
(CPP)とは、一般に牛乳のたんぱく質に酵素を反応
させ、製造されるペプチドであり、カルシウム吸収を助
長する働きがあるとされている特定保健用食品素材の一
つである。本発明に使用されるカゼインホスホペプチド
(CPP)は市販のものでもよく、また、本発明のダイ
エット向上食品に植物性フラボノイドを添加すると腸管
での脂肪分解酵素活性が高くなる。これは、フラボノイ
ドの持つ抗酸化性がダイエット向上菌体の保存性を高
め、腸内の大腸菌等の悪玉菌の増殖がフラボノイドの抗
菌活性のため抑制されるためであると推定される。本発
明に添加されるフラボノイドは、食用として許容される
安全性の高いものであればよいが、その入手の容易さ、
価格の安さ、効果の高さから、フラボノイドがブドウ
科、ミカン科、茶、バラ科の植物から選択された植物よ
り抽出されたフラボノイド類が好ましい。次に、本発明
に使用できる脂肪分解酵素の製造方法の一例を示す。本
発明に使用できる脂肪分解酵素の製造方法は、通常の脂
肪分解酵素の製造方法を用いることができ、例えば殺菌
した乳を主成分とする培地に、脂肪分解酵素グレインを
添加し、発酵温度を15〜25℃に保持し、24時間程
度発酵させ製造することもできる。これを凍結乾燥処理
し、長時間法で生存率を高めたFD肪分解酵素(Freeze
Dried脂肪分解酵素)である。
Means for Solving the Problems In order to solve the above problems, the present inventors have established a method for increasing the survival rate of viable bacteria by freeze-drying lipolytic enzymes, We searched for additives to grow actively in the intestine.
As a result, it was found that when the following substances were mixed with the dried lipolytic enzyme and fed to a human, the lipolytic enzyme began to proliferate actively in the intestinal tract of the human under any conditions, improving intestinal health. Was. This has been found to improve the intestinal environment, and in particular to efficiently digest and absorb and decompose excessive fats and carbohydrates, and to be a health maintenance food that enhances metabolism and enhances immunostimulatory activity. In other words, by linking lipolytic enzymes (lipases) produced by co-cultivating lactic acid bacteria and yeast to be used in food with intestinal bacteria, natural plants and fruits are subjected to oxygen treatment and then produced to contain this pectin. It has been found that the activity of the lipolytic enzyme is increased in the intestine by mixing the plant and fruit enzyme-treated powder to produce an ideal lipolytic enzyme food. In addition, in particular, plants, fruit enzyme-treated powders, oligosaccharides, casein phosphopeptides (CPPs), which associate lipolytic enzymes (lipases) produced by co-cultivating lactic acid bacteria and yeast provided in foods with enteric bacteria, ) Is added to the diet-enhancing diet, the effect of decomposing intestinal fat and the effect of decomposing intestinal carbohydrates are further enhanced.
In addition, by linking lipolytic enzymes (lipases) produced by co-cultivating lactic acid bacteria and yeast provided to food with intestinal bacteria, activation of lipolytic enzymes in the intestine and carbohydrate degradation The activation of cellulase, hemicellulase, pectinase, xylanase, galactopyranosidase, and one or two or more enzymes selected from arabinofuranosidase are used for the enzyme treatment, and lipolytic enzymes in the intestine are used. It could be verified that the activity was higher. From these results, the present invention has been completed. That is, the above-described problem is caused by the obesity obtained by blending lipolytic enzymes produced by co-culturing lactic acid bacteria and yeast provided for food, enterobacteria, proliferating oligosaccharides, and plant fibers. Solved by prevention food. The lipolytic enzyme used in the present invention may be any plant fiber degrading enzyme, such as cellulase, pectinase, xylanase,
One or more enzymes selected from mannanase, galactopyranosidase and arabinofuranosidase may be used. Preferably, the use of pectinase or xylanase further enhances the activity of the lipolytic enzyme in the intestine. When the enzyme used in the present invention is a natural extraction enzyme, those containing digestive enzymes such as amylase and protease as its accessory components can also be used. The amount of the enzyme used in the enzyme treatment of the present invention varies depending on the potency and the amount of the plant to be treated. The reaction is carried out at an enzyme reaction temperature of 5 ° C. to 50 ° C. for 10 minutes to 36 hours. Peptone, glucose, KH 2 PO 4, NaNO 3 , MgSO 4, PH6.
0 As the lipolytic enzyme used in the present invention, commercially available cellulase or the like can be used, but the plant to be treated with the enzyme in the present invention may be any one containing a plant fiber that promotes the activity of the lipolytic enzyme. Good examples are oranges,
Citrus family such as oranges, grape family, cucumber, melon etc., solanaceae family such as tomato and eggplant, persimmon family such as persimmon, rose family such as strawberry, apple, pear, buckthorn family such as jujube, radish, cabbage And plants selected from root crops such as rape, radish, carrot and burdock, potatoes such as sweet potato and yam, and grains such as rice and wheat. Plants containing plant fibers that promote the activity of the lipolytic enzyme of the present invention were selected by the following method for examining the lipolytic enzyme growth activity. The method is described below. 1000 kg of purified water is added to 10 kg of the plant to be investigated, and the mixture is thoroughly crushed with a homogenizer. 0.5 g of hemicerase is added to the plant juice and incubated at 40 ° C. for 3 hours. This is heat-treated at 100 ° C. for 30 minutes, and after cooling, the plant cellulase-treated solution and milk are mixed at a ratio of 1: 9 to obtain a lipolytic enzyme culture solution. Twenty grains of lipolytic enzyme having an average particle size of 1 mm are spread on a petri dish together with the lipolytic enzyme culture solution prepared above, and cultured at 20 ° C. for 5 days. At this time, the culture solution is changed every day. After the culture, the shape of the lipolytic enzyme granules is observed with a loupe, and the average particle size of the grown lipolytic enzyme granules is measured. As a control, the lipolytic enzyme particle size similarly cultured in the same milk diluted to 90% with purified water is measured, and after 5 days, the ratio of the particle size to the control is calculated. At this time, the ratio of the particle size to the control is 120%.
If so, the plant is to promote lipolytic enzyme activity. Plants used in the present invention are more preferably mature and softened as much as possible. First, a plant containing a plant fiber that promotes the growth of the lipolytic enzyme granules selected above is finely pulverized by a mixer into a juice. At this time, if necessary, purified water having a weight of 0.1 to 2 times may be added. Cellulase is added to the plant juice in an amount of 0.1% to 5% by weight based on the weight of the plant, and the mixture is reacted at a leap of 10 ° C to 50 ° C for 3 hours to 4 hours. next,
Heat treatment at a temperature of 60 ° C. to 130 ° C. for 3 seconds to 60 minutes. Thereafter, drying is performed until the water content becomes 5% or less. Drying conditions may be heat drying, freeze drying or vacuum drying,
There is no particular limitation. In the present invention, the cellulase-treated and heat-treated plant and fruit enzyme-treated powders are added to the diet-enhancing food powder in a range of 0.5 to 50% by weight. The plant and fruit enzyme-treated powder used in the present invention may be a plant fiber component such as pectin and its decomposed product, and in the case of pectin, either a purified product or a crude product can be used. Pectin produced from plant fiber. The reason is that cellulose obtained by hydrolyzing the plant selected in the present invention with cellulase has higher lipolytic enzyme activity than purified commercial pectin. However, if necessary, commercially available purified pectin can be added to increase the amount. The lipolytic enzyme used in the present invention has a cauliflower-like elasticity composed of a complex symbiotic group (known as lipolytic enzyme grains or lipolytic enzyme granules) composed of dozens of known lactic acid bacteria and yeast. It is obtained from a fermentation product produced by fermenting grains as a starter, and is qualitatively different from a normal fermented food to which lactic acid bacteria and yeast are added or mixed and a dried product thereof. In addition, as a characteristic of the lipolytic enzyme used in the present invention, it contains the following main bacterial species, undergoes lactic acid fermentation and alcoholic fermentation, and uses lipolytic enzyme grains that meet these conditions. I just need. The lipolytic enzyme used in the present invention may be any one containing at least the following bacterial species. That is, lactic acid bacteria include Lactobacillus, Streptococcus, Lactococcus, Leuconostocs, and yeasts such as Saccharomyces and Candida. Oligosaccharides to be added to the present invention may be oligosaccharides such as fructooligosaccharides, isomaltoligosaccharides, galactooligosaccharides (including raffinose and stachyose), balatinose, coupling sugars, pectin oligos and the like. Natural extracts, fermented products and Any of the chemically synthesized products can be used. Casein phosphopeptide (CPP) to be added to the present invention is a peptide generally produced by reacting an enzyme with a protein of milk, and is a food material for specified health use which is said to have a function of promoting calcium absorption. One. The casein phosphopeptide (CPP) used in the present invention may be a commercially available case, and the addition of a vegetable flavonoid to the diet-enhancing food of the present invention increases the lipolytic enzyme activity in the intestinal tract. This is presumed to be because the antioxidant property of the flavonoid enhances the preservability of the diet-enhancing cells, and the growth of bad bacteria such as Escherichia coli in the intestine is suppressed due to the antibacterial activity of the flavonoid. Flavonoids to be added to the present invention may be any edible and highly safe ones, but their availability is easy,
Flavonoids in which flavonoids are extracted from plants selected from grape, citrus, tea, and rose family are preferred from the viewpoint of low price and high effect. Next, an example of a method for producing a lipolytic enzyme that can be used in the present invention will be described. The method for producing a lipolytic enzyme that can be used in the present invention can use a general method for producing a lipolytic enzyme.For example, a lipolytic enzyme grain is added to a medium containing sterilized milk as a main component, and the fermentation temperature is reduced. It can also be produced by keeping at 15 to 25 ° C. and fermenting for about 24 hours. This is freeze-dried, and the FD lipolytic enzyme (Freeze
Dried lipolytic enzyme).

【発明の実施の形態】以下に本発明の実施例及び比較例
を示す。
DESCRIPTION OF THE PREFERRED EMBODIMENTS Examples and comparative examples of the present invention will be described below.

【実施例1】以下のダイエット向上食品粉末には、FD
脂肪分解酵素を用いた。まず、熟して軟質化したトマト
200g、リンゴ200g、キュウリ200g、ダイコ
ン200g、カンショ200gをよく洗浄した後、精製
水0.2Lを加えてジューサーを用いて細かく粉砕し、
ジュース状にした。この植物ジュースに植物重量に対し
1%のセルラーゼを添加し、35℃で10時間反応させ
た。次に、このジュースをオートクレープで121℃で
20分間煮沸し、酵素活性を失活させるとともに滅菌し
た。この後、定法によりスプレードライヤーで乾操さ
せ、水分が13.5%の植物繊維粉末を得た。この植物
粉末をさらにボールミルで粉砕した後、ステンレス篩に
て80メッシュパスのパウダーと、これを本発明で使用
するセルラーゼ処理及び加熱処理された植物、果実酵素
処理粉末(以下単に植物、果実酵素処理粉末という)と
した。
Example 1 The following diet-enhancing food powders are FD
Lipolytic enzymes were used. First, after thoroughly washing 200 g of ripe and softened tomatoes, 200 g of apples, 200 g of cucumber, 200 g of radish, and 200 g of sweet potato, 0.2 L of purified water was added, and finely ground using a juicer.
Juicy. 1% of cellulase based on the plant weight was added to the plant juice and reacted at 35 ° C. for 10 hours. Next, the juice was boiled in an autoclave at 121 ° C. for 20 minutes to inactivate the enzyme activity and sterilize. Thereafter, the resultant was dried with a spray drier according to a standard method to obtain a vegetable fiber powder having a water content of 13.5%. After the plant powder is further pulverized by a ball mill, a powder of 80 mesh pass is passed through a stainless sieve, and the cellulase-treated and heat-treated plant and fruit enzyme-treated powder used in the present invention (hereinafter simply referred to as plant and fruit enzyme treatment) Powder).

【実施例2】上記のダイエット向上食品粉末、植物、果
実酵素処理粉末、オリゴ糖混合物を用いて以下の組成の
粉末状脂肪分解酵素食品を製造した。なお、ここで使用
したオリゴ塘混合物とはフラクトオリゴ糖20%、イソ
マルトオリゴ糖20%、ガラクトオリゴ糖20%、パラ
チノース20%、カップリングシュガー20%重量を含
有するものである。 ダイエット向上食品粉末 40% 植物、果実酵素処理粉末 30% オリゴ糖混合物 30%
Example 2 A powdery lipolytic enzyme food having the following composition was produced using the above-mentioned diet-enhancing food powder, plant and fruit enzyme-treated powder, and oligosaccharide mixture. In addition, the oligo-tang mixture used here contains 20% of fructooligosaccharides, 20% of isomaltoligosaccharides, 20% of galactooligosaccharides, 20% of palatinose, and 20% of coupling sugar. Diet-enhancing food powder 40% Plant and fruit enzyme-treated powder 30% Oligosaccharide mixture 30%

【実施例3】上記の乾操脂肪分解酵素粉末、植物、果実
酵素処理粉末及びフラクトオリゴ糖、カゼインホスホペ
プチド(CPP)を用いて以下の組成の粉末状脂肪分解
酵素食品を製造した。 乾燥脂肪分解酵素粉末 33% 植物、果実酵素処理粉末 33% フラクトオリゴ糖混合物 20% カゼインホスホペプチド(CPP) 10% 乳糖
Example 3 A powdery lipolytic enzyme food having the following composition was produced using the above-mentioned dry lipolytic enzyme powder, plant and fruit enzyme-treated powder, fructooligosaccharide and casein phosphopeptide (CPP). Dry lipolytic enzyme powder 33% Plant and fruit enzyme-treated powder 33% Fructooligosaccharide mixture 20% Casein phosphopeptide (CPP) 10% Lactose

【実施例4】上記の乾操脂肪分解酵素粉末、植物、果実
酵素処理粉末及びフラクトオリゴ糖、カゼインホスホペ
プチド(CPP)を用いて以下の組成の粉末状脂肪分解
酵素食品を製造した。 乾燥脂肪分解酵素粉末 30% 植物、果実酵素処理粉末 20% フラクトオリゴ糖 20% カゼインホスホペプチド(CPP) 20% 乳糖
Example 4 A powdery lipolytic enzyme food having the following composition was produced by using the above-mentioned dried lipolytic enzyme powder, plant and fruit enzyme-treated powder, fructooligosaccharide and casein phosphopeptide (CPP). Dry lipolytic enzyme powder 30% Plant and fruit enzyme-treated powder 20% Fructooligosaccharide 20% Casein phosphopeptide (CPP) 20% Lactose

【実施例5】上記の乾燥脂肪分解酵素粉末、植物、果実
酵素処理粉末及び太陽化学社製のポリフェノール混合物
を用いて以下の組成の粉末状脂肪分解酵素食品を製造し
た。 乾燥脂肪分解酵素粉末 30% 植物、果実酵素処理粉末 20% フラクトオリゴ糖 20% カゼインホスホペプチド(CPP) 20% 乳糖 9% ポリフェノール混合物 1% (ポリフェノール混合物とは、ブドウ抽出ポリフェノー
ル20%、ミカン抽出ポリフェノール20%、茶抽出ポ
リフェノール40%、リンゴ抽出ポリフェノール20%
重量から成る。)
Example 5 A powdery lipolytic enzyme food having the following composition was produced using the above-mentioned dry lipolytic enzyme powder, plant and fruit enzyme-treated powder and a polyphenol mixture manufactured by Taiyo Kagaku. Dry lipolytic enzyme powder 30% Plant and fruit enzyme-treated powder 20% Fructooligosaccharide 20% Casein phosphopeptide (CPP) 20% Lactose 9% Polyphenol mixture 1% (Polyphenol mixture is grape extracted polyphenol 20%, mandarin extracted polyphenol 20 %, Tea extracted polyphenol 40%, apple extracted polyphenol 20%
Consist of weight. )

【実施例6】腸に不調を訴える年齢25歳から55歳ま
での男女100人を20人づつ5グループに分け、その
内の4グループをそれぞれ試験区1、試験区2、試験区
3、試験区4として下表に示す本発明の乾燥脂肪分解酵
素食品を摂取し、残りの1グループを対象区としてのビ
フィズス菌利用食品を摂取させた。摂取方法は1日3回
毎食前に3gづつ摂取させた。3日後に被験者に対する
アンケートによって腸の状態を、次ぎの基準で点数化し
たところ各試験区合計点数が対象区のそれよりも目覚し
く増加し、本発明の乾操脂肪分解酵素食品の効果が証明
された。又、対象区の被験者には消化不良症状が見られ
腸内環境が悪かったのに対して、試験区では消化不良症
状は見られず腸内環境が改善されたことが示唆された。
Example 6 100 men and women aged 25 to 55 years old who complain of intestinal upset were divided into 5 groups of 20 persons each, and 4 groups were divided into test group 1, test group 2, test group 3, test group The dried lipolytic enzyme food of the present invention shown in the following table was ingested as the section 4 and the remaining one group was ingested with the bifidobacteria-based food as the target section. As an ingestion method, 3 g was ingested three times a day before each meal. Three days later, the intestinal condition was scored by the questionnaire to the subjects according to the following criteria. When the total score of each test plot increased remarkably than that of the target plot, the effect of the dry lipolytic enzyme food of the present invention was proved. Was. In addition, the subjects in the control group showed indigestion symptoms and the intestinal environment was bad, whereas the test group showed no indigestion symptoms, suggesting that the intestinal environment was improved.

【発明の効果】本発明の食品は、脂肪分解酵素を含む微
生物が人の腸内で効率よく活性化され、その結果肥満の
原因となる脂肪や、糖質が効果的に代謝され、これによ
り腸内環境が著しく改善され、さらには人体細胞の活性
化にとって欠かすことのできないエネルギーは十分に得
られ、食物の消化吸収を向上させ健康を維持して病気を
予防し得ることが確認できた。
In the food of the present invention, microorganisms containing lipolytic enzymes are efficiently activated in the human intestine, and as a result, fats and carbohydrates that cause obesity are effectively metabolized. It was confirmed that the intestinal environment was remarkably improved, and that the energy necessary for the activation of human body cells was sufficiently obtained, and that digestion and absorption of food could be improved, health could be maintained, and diseases could be prevented.

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】 食品に供される乳酸菌と酵母とを共生培
養することにより生成された脂肪分解酵素と、腸内細菌
と、増殖するオリゴ糖と、植物繊維とが配合されてなる
肥満防止食品。
Claims: 1. An anti-obesity food comprising a lipolytic enzyme produced by co-cultivating lactic acid bacteria and yeast provided in food, intestinal bacteria, proliferating oligosaccharides, and plant fiber. .
【請求項2】 前記乳酸菌は、ラクトバチルス・ケフィ
ラノフェシェンス、ラクトバチルス・アシドフェリス、
ラクトバチルス・ファメンタム、ラクトコッカス・ラク
チス、エンテロコッカス・フェイカリス、ロイコノコッ
カス・メッセンテロィデスであることを特徴とする請求
項1記載の肥満防止食品。
2. The lactic acid bacterium according to claim 1, wherein the lactic acid bacterium comprises Lactobacillus kefiranofeshens, Lactobacillus acidoferris,
2. The anti-obesity food according to claim 1, wherein the food is Lactobacillus famentum, Lactococcus lactis, Enterococcus faecalis, or Leuconococcus mescenteroides.
【請求項3】 前記酵母は、サッカロマイセス・デルフ
リキィー、サッカロマイセス?・セレェヴィシェー、キ
ャンジダ・ホルミィー、サッカロマイセス・フラギリ
ス、キャンジダ・ケフィァー、アスペルギルス・オリー
ゼであることを特徴とする請求項1記載の肥満防止食
品。
3. The yeast according to claim 1, wherein the yeast is Saccharomyces del Flicii, Saccharomyces? 2. The anti-obesity food according to claim 1, wherein the food is selected from the group consisting of Seleviche, Candida Holmy, Saccharomyces fragilis, Candida Kefir, and Aspergillus oryzae.
JP2000112475A 2000-04-13 2000-04-13 Obesity-preventive food Pending JP2001292728A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2000112475A JP2001292728A (en) 2000-04-13 2000-04-13 Obesity-preventive food

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000112475A JP2001292728A (en) 2000-04-13 2000-04-13 Obesity-preventive food

Publications (1)

Publication Number Publication Date
JP2001292728A true JP2001292728A (en) 2001-10-23

Family

ID=18624635

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000112475A Pending JP2001292728A (en) 2000-04-13 2000-04-13 Obesity-preventive food

Country Status (1)

Country Link
JP (1) JP2001292728A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007085970A3 (en) * 2006-01-27 2008-05-08 Danisco Use of probiotic microorganisms for the treatment and prevention of obesity and related disorders
EP2431044A1 (en) 2005-10-07 2012-03-21 Arla Foods Amba Probiotics to influence fat metabolism and obesity

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63254961A (en) * 1987-04-13 1988-10-21 Showa Sangyo Co Ltd Preparation of health food
JPH05168432A (en) * 1991-12-19 1993-07-02 Sunstar Inc Material for oligosaccharide-containing food and drink, food and drink containing the same and production of the same material
JPH07145A (en) * 1991-07-10 1995-01-06 Miyarisan Seibutsu Igaku Kenkyusho:Kk Composition of butyric acid bacterium
JPH07155103A (en) * 1993-12-08 1995-06-20 Shikoku Nyugyo Kk Method for producing lactic bacteria fermentation solution
JPH08294379A (en) * 1995-04-27 1996-11-12 Hisae Toiba Preparation of fermented yacon drink
JPH0937711A (en) * 1995-07-28 1997-02-10 Sennosuke Tokumaru Health food
JPH0965855A (en) * 1995-08-28 1997-03-11 Otsuka Shokuhin Kk Low-caloric food material for controlling intestinal function
JP2000032909A (en) * 1998-07-21 2000-02-02 Bio Health:Kk Food for improving digestion and absorption by environmental improvement caused by enteric microbe

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63254961A (en) * 1987-04-13 1988-10-21 Showa Sangyo Co Ltd Preparation of health food
JPH07145A (en) * 1991-07-10 1995-01-06 Miyarisan Seibutsu Igaku Kenkyusho:Kk Composition of butyric acid bacterium
JPH05168432A (en) * 1991-12-19 1993-07-02 Sunstar Inc Material for oligosaccharide-containing food and drink, food and drink containing the same and production of the same material
JPH07155103A (en) * 1993-12-08 1995-06-20 Shikoku Nyugyo Kk Method for producing lactic bacteria fermentation solution
JPH08294379A (en) * 1995-04-27 1996-11-12 Hisae Toiba Preparation of fermented yacon drink
JPH0937711A (en) * 1995-07-28 1997-02-10 Sennosuke Tokumaru Health food
JPH0965855A (en) * 1995-08-28 1997-03-11 Otsuka Shokuhin Kk Low-caloric food material for controlling intestinal function
JP2000032909A (en) * 1998-07-21 2000-02-02 Bio Health:Kk Food for improving digestion and absorption by environmental improvement caused by enteric microbe

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2431044A1 (en) 2005-10-07 2012-03-21 Arla Foods Amba Probiotics to influence fat metabolism and obesity
WO2007085970A3 (en) * 2006-01-27 2008-05-08 Danisco Use of probiotic microorganisms for the treatment and prevention of obesity and related disorders
US8257695B2 (en) 2006-01-27 2012-09-04 Dupont Nutrition Biosciences Aps Method for modulating satiety signaling with specific strains of Lactobacillus acidophilus and Bacillus

Similar Documents

Publication Publication Date Title
CN103932344B (en) Fermentation preparation method for edible fungus probiotics health-care drink
CN102613329B (en) Preparation method of raw tea enzyme and raw tea enzyme
CN105123931A (en) Probiotic foodstuff and preparation method thereof
CN105028646A (en) Freeze-dried tablets and preparation method thereof
CN105455135A (en) Method for preparing alcohol-free compound enzyme of Nan helianthus tuberosus No. 9 and fruits and vegetables
CN105123925A (en) Freeze-dried foodstuff and preparation method thereof
CN102273548B (en) Feeding microecological preparation and preparation method thereof
CN102302058A (en) Effervescent tablets of high-viscosity yoghurt fermenting agent and preparation method and application thereof
CN105028637A (en) Fruit puree tablet containing probiotics and preparation method for fruit puree tablet
CN105123949A (en) Yoghourt tablet containing live bacteria and preparation method thereof
CN105104529A (en) Lactobacillus food and preparation method thereof
JP2000032909A (en) Food for improving digestion and absorption by environmental improvement caused by enteric microbe
KR20200087388A (en) Animal feed additive using agricultural wastes and process for preparing the same
CN105076413A (en) Fruit and vegetable tablet containing lactic acid bacteria and preparation method of fruit and vegetable tablet
CN105123932A (en) Fruit and vegetable probiotic tablet and preparation method thereof
JP4183371B2 (en) Manufacturing method of fermented turmeric
CN113367289A (en) Production process of plant yoghourt capable of being stored at normal temperature
CN105076412A (en) Fruit pulp food containing lactobacillus and preparation method thereof
CN105028640A (en) Fruit puree food and preparation method thereof
CN110419584A (en) A kind of fermenting plant protein food and preparation method thereof
KR101841909B1 (en) Culture method of lactic acid bacteria using nuruk and mixed grains
CN105123934A (en) Fruit paste foodstuff containing probiotics and preparation method thereof
CN105123924A (en) Fruit paste probiotic tablet and preparation method thereof
CN105104530A (en) Fruit and vegetable food and preparation method thereof
CN107494735A (en) It is a kind of containing resistant starch, Juice and the health care yoghourt of edible mushroom

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060407

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20070125

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20070131

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070326

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20081008

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090225